AAAAAA

   
Results: 1-12 |
Results: 12
Pemoline hepatotoxicity and postmarketing surveillance
Authors: Safer, DJ Zito, JM Gardner, JF
Citation: Dj. Safer et al., Pemoline hepatotoxicity and postmarketing surveillance, J AM A CHIL, 40(6), 2001, pp. 622-629
Mental health services for youths in foster care and disabled youths
Authors: dosReis, S Zito, JM Safer, DJ Soeken, KL
Citation: S. Dosreis et al., Mental health services for youths in foster care and disabled youths, AM J PUB HE, 91(7), 2001, pp. 1094-1099
Psychotropic medication in children: A study from the Netherlands
Authors: Schirm, E Tobi, H Zito, JM de Jong-van den Berg, LTW
Citation: E. Schirm et al., Psychotropic medication in children: A study from the Netherlands, PEDIATRICS, 108(2), 2001, pp. NIL_30-NIL_33
Services and prevention: Pharmacoepidemiology of antidepressant use
Authors: Zito, JM Safer, DJ
Citation: Jm. Zito et Dj. Safer, Services and prevention: Pharmacoepidemiology of antidepressant use, BIOL PSYCHI, 49(12), 2001, pp. 1121-1127
Building pharmacoepidemiological capacity to monitor psychotropic drug useamong children enrolled in medicaid
Authors: Fox, MH Foster, CH Zito, JM
Citation: Mh. Fox et al., Building pharmacoepidemiological capacity to monitor psychotropic drug useamong children enrolled in medicaid, AM J MED QU, 15(4), 2000, pp. 126-136
Trends in the prescribing of psychotropic medications to preschoolers
Authors: Zito, JM Safer, DJ dosReis, S Gardner, JF Boles, M Lynch, F
Citation: Jm. Zito et al., Trends in the prescribing of psychotropic medications to preschoolers, J AM MED A, 283(8), 2000, pp. 1025-1030
Psychotropic medication for ADHD
Authors: Safer, DJ Zito, JM
Citation: Dj. Safer et Jm. Zito, Psychotropic medication for ADHD, MENT RET D, 5(3), 1999, pp. 237-242
Novel antipsychotic medications in the treatment of children and adolescents
Authors: Malone, RP Sheikh, R Zito, JM
Citation: Rp. Malone et al., Novel antipsychotic medications in the treatment of children and adolescents, PSYCH SERV, 50(2), 1999, pp. 171-174
Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder
Authors: Zito, JM Safer, DJ dosReis, S Magder, LS Gardner, JF Zarin, DA
Citation: Jm. Zito et al., Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder, ARCH PED AD, 153(12), 1999, pp. 1257-1263
Dopamine, receptor occupancy and the action of clozapine: Does it make a difference to add a neuroleptic? Reply
Authors: Carpenter, WT Zito, JM Volavka, J
Citation: Wt. Carpenter et al., Dopamine, receptor occupancy and the action of clozapine: Does it make a difference to add a neuroleptic? Reply, BIOL PSYCHI, 46(1), 1999, pp. 147-149
Racial disparity in medications prescribed - Drs. Zito and Safer reply
Authors: Zito, JM Safer, DJ
Citation: Jm. Zito et Dj. Safer, Racial disparity in medications prescribed - Drs. Zito and Safer reply, J AM A CHIL, 37(12), 1998, pp. 1242-1242
Clinical and treatment characteristics of children with attention-deficit/hyperactivity disorder in psychiatric practice
Authors: Zarin, DA Suarez, AP Pincus, HA Kupersanin, E Zito, JM
Citation: Da. Zarin et al., Clinical and treatment characteristics of children with attention-deficit/hyperactivity disorder in psychiatric practice, J AM A CHIL, 37(12), 1998, pp. 1262-1270
Risultati: 1-12 |